Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS Longitudinal CF Sputum Samples

ABSTRACT: A collection of sputum samples collected from cystic fibrosis patients. These samples were collected daily from 6 patients for over 1 year.

INSTRUMENT(S): maXis

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Pieter Dorrestein Robert Quinn

PROVIDER: MSV000082667 | GNPS | Fri Jul 27 15:10:00 BST 2018

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Similar Datasets

Microbial ecology of nontuberculous mycobacteria (NTM) in cystic fibrosis (CF) sputum

Project description:These are sputum samples collected from 8 individuals with cystic fibrosis during the course of routine clinical care. They were initially stored at 4C for up to 24 hours then stored at -80C. No processing has been done to the sputum prior to freezing. For each individual there are sputum samples collected both before and after the individual had his or her first positive sputum culture for nontuberculous mycobacteria (NTM). The individuals experienced different clinical courses after their infection.

2017-06-19 | ST000711 | MetabolomicsWorkbench

Single Cell sequencing of human Sputum cells in cystic fibrosis and healthy controls

Project description:The study aimed to compare the gene expression profiles at a single cell level in Sputum cells between patients with cystic fibrosis (CF) and disease controls (CTRL).

2020-07-01 | GSE145360 | GEO

Transcription profiling of Burkholderia cepacia grown in cystic fibrosis sputum

Project description:Transcriptome profile of B. cenocepacia grown in cystic fibrosis sputum

2008-01-01 | E-MEXP-1261 | biostudies-arrayexpress

GNPS GC Data XSectinoal CF Sputum

Project description:A collection of sputum and mouth rinse samples from cystic fibrosis patients collected cross sectionally. GC-MS data!!

2017-06-09 | MSV000081150 | GNPS

Pseudomonas aeruginosa gene expression in artificial sputum medium using a broad capture array designated the PANarray

Project description:The PANarray design (GPL13324) contains the genes of eight P. aeruginosa genomes in non-redundant format, thus allowing identification of expression of non-PAO1 and other P. aeruginosa genes. For the series GSE28152, isogenic isolates were sequentially collected from two cystic fibrosis (CF) patients several years apart. The isolates had not been eradicated in the meantime and represent persister strains. One was an Australian Epidemic Strain-1 isolate and the other a non-epidemic strain. Strains were cultured in an artificial sputum medium (ASMDM) closely resembling CF sputum.

2011-07-15 | E-GEOD-28152 | biostudies-arrayexpress

Transcription profiling by array of Pseudomonas aeruginosa wild-type and phhR mutants grown in a defined synthetic cystic fibrosis sputum medium with and without aromatic amino acids

Project description:Arrays comparing Pseudomonas aeruginosa growth in a defined synthetic cystic fibrosis sputum medium with and without aromatic amino acids. Additional arrays comparing wild-type Pseudomonas aeruginosa and phhR mutant P. aeruginosa in defined synthetic cystic fibrosis sputum medium.

2010-04-01 | E-MEXP-2593 | biostudies-arrayexpress

Transcription profiling of Pseudomonas aeruginosa PA14 grown in aerobic or anaerobic conditions in cystic fibrosis sputum with added nitrate

Project description:Effect of anaerobic growth condition on gene expression profile of Pseudomonas aeruginosa PA14 grown in cystic fibrosis sputum with 100 mM nitrate added

2007-06-01 | E-MEXP-1051 | biostudies-arrayexpress

Antibiotics in Cystic Fibrosis Sputum

Project description:Detection of 18 antibiotics in 171 cystic fibrosis sputum samples from the Phase 1 Clinical Study.

2020-04-23 | ST001365 | MetabolomicsWorkbench

CF sputum LC-MSMS - Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with Pseudomonas aeruginosa

Project description:Lung disease is the main cause of morbidity and mortality in cystic fibrosis (CF), and involves chronic infection by a destructive microbiota and perturbed innate and adaptive immune responses. Tissue damage is considered to be mediated mostly by proteases, but other bacterial and host factors may also play a role. To determine the presence of potentially injurious proteins we employed semi-quantitative Multidimensional Protein Identification Technology to identify sputum cellular proteins with consistently altered expression in CF compared to healthy controls. Ingenuity Pathway Analysis, Gene Ontology functions, protein abundance and correlation with lung function were used to infer their clinical significance. The CF proteome exhibited differential expression of proteins relating to Rho family small GTPase activity, immune cell movement and activation, generation of reactive oxygen species and dysregulation of cell death and proliferation. Compositional breakdown established neutrophil extracellular trap proteins as the consistently most abundant cellular proteins detected, while a further 13 biologically relevant proteins were found to correlate negatively with lung function. These findings expand the current understanding of the mechanisms underlying CF lung disease and identify sputum cell proteins which might be useful as markers of disease status, prognostic indicators, stratification determinants for treatment prescription or as therapeutic targets.

2017-05-19 | PXD001985 | Pride

Characterisation of the Microbiota of Sputum Samples Derived from Cystic Fibrosis Patients at Different Centres

Project description:The aim of this study is to characterise and compare the composition of the microbiota from sputum samples of cystic fibrosis sufferers from different centres. These data are part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/

2014-09-16 | E-ERAD-265 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data